Status:
COMPLETED
Phase Out in Tinnitus Patients
Lead Sponsor:
University Hospital, Antwerp
Conditions:
Tinnitus
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Phase shift treatment is a new tinnitus therapy that aims at sound cancelling via complete or partial residual inhibition. This technique is based on the theory by Choy advocating that the induction o...
Eligibility Criteria
Inclusion
- consult ENT department UZA with tinnitus
- pure tone tinnitus or narrow band noise tinnitus
- unilateral tinnitus, or bilateral tinnitus if both ears pure tone or both ears narrow band noise
- frequency tinnitus \> 1kHz
- cochlear origin tinnitus
- tinnitus duration 3 months or longer
- age 18y or more
- patient being able to cooperate
- patiënt able to fill in VAS
- normal MRI pontine angle
Exclusion
- depression: BDI \> 21
- pulsatile tinnitus
- pregnancy
- epilepsy
Key Trial Info
Start Date :
March 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00833950
Start Date
March 1 2008
Last Update
March 3 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Antwerp university Hospital
Edegem, Antwerp, Belgium, 2650